SMYD3 and B-cell chronic lymphocytic leukemia: Furthermore, the STAT3 inhibitor WP1066 has been shown to downregulate SMYD3 transcription by inhibiting the binding of STAT3 to the SMYD3 promoter, suppressing chronic lymphocytic leukemia cell growth in vivo99.